Bukavina, L. et al. Epidemiology of renal cell carcinoma: 2022 update. Eur. Urol. 82, 529–542 (2022).

Article  PubMed  Google Scholar 

Escudier, B. et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 30, 706–720 (2019).

Article  CAS  PubMed  Google Scholar 

Schieda, N. et al. Active surveillance of renal masses: the role of radiology. Radiology 302, 11–24 (2022).

Article  PubMed  Google Scholar 

Siva, S. et al. Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach. Nat. Rev. Urol. 14, 549–563 (2017).

Article  PubMed  Google Scholar 

Young, M. et al. Renal cell carcinoma. Lancet 404, 476–491 (2024).

Article  CAS  PubMed  Google Scholar 

Ghoreifi, A., Vaishampayan, U., Yin, M., Psutka, S. P. & Djaladat, H. Immune checkpoint inhibitor therapy before nephrectomy for locally advanced and metastatic renal cell carcinoma: a review. JAMA Oncol. 10, 240–248, (2024).

Article  PubMed  Google Scholar 

Catalano, M. et al. Tyrosine kinase and immune checkpoints inhibitors in favorable risk metastatic renal cell carcinoma: Trick or treat? Pharmacol. Ther. 249, 108499 (2023).

Article  CAS  PubMed  Google Scholar 

Wang, Y. et al. Evolution of cell therapy for renal cell carcinoma. Mol. Cancer 23, 8 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Mankoff, D. A. A definition of molecular imaging. J. Nucl. Med. 48, 18N, 21N (2007).

PubMed  Google Scholar 

Wei, W. et al. ImmunoPET: concept, design, and applications. Chem. Rev. 120, 3787–3851 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rahmim, A. et al. Dynamic whole-body PET imaging: principles, potentials and applications. Eur. J. Nucl. Med. Mol. Imaging 46, 501–518 (2019).

Article  PubMed  Google Scholar 

James, M. L. & Gambhir, S. S. A molecular imaging primer: modalities, imaging agents, and applications. Physiol. Rev. 92, 897–965 (2012).

Article  CAS  PubMed  Google Scholar 

Ametamey, S. M., Honer, M. & Schubiger, P. A. Molecular imaging with PET. Chem. Rev. 108, 1501–1516 (2008).

Article  CAS  PubMed  Google Scholar 

Zhou, X., Shi, B., Huang, G., Liu, J. & Wei, W. Trends in cancer imaging. Trends Cancer https://doi.org/10.1016/j.trecan.2024.08.006 (2024).

Cheal, S. M., Chung, S. K., Vaughn, B. A., Cheung, N. V. & Larson, S. M. Pretargeting: a path forward for radioimmunotherapy. J. Nucl. Med. 63, 1302–1315 (2022).

Article  CAS  PubMed  Google Scholar 

Larson, S. M., Carrasquillo, J. A., Cheung, N. K. & Press, O. W. Radioimmunotherapy of human tumours. Nat. Rev. Cancer 15, 347–360 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aboagye, E. O., Barwick, T. D. & Haberkorn, U. Radiotheranostics in oncology: making precision medicine possible. CA Cancer J. Clin. 73, 255–274 (2023).

Article  PubMed  Google Scholar 

Herrmann, K. et al. Radiotheranostics: a roadmap for future development. Lancet Oncol. 21, e146–e156 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ljungberg, B. et al. European Association of Urology guidelines on renal cell carcinoma: the 2022 update. Eur. Urol. 82, 399–410 (2022).

Article  PubMed  Google Scholar 

Rathmell, W. K. et al. Management of metastatic clear cell renal cell carcinoma: ASCO guideline. J. Clin. Oncol. 40, 2957–2995 (2022).

Article  CAS  PubMed  Google Scholar 

Rossi, S. H., Prezzi, D., Kelly-Morland, C. & Goh, V. Imaging for the diagnosis and response assessment of renal tumours. World J. Urol. 36, 1927–1942 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Furrer, M. A. et al. Comparison of the diagnostic performance of contrast-enhanced ultrasound with that of contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging in t he evaluation of renal masses: a systematic review and meta-analysis. Eur. Urol. Oncol. 3, 464–473 (2020).

Article  PubMed  Google Scholar 

Vogel, C. et al. Imaging in suspected renal-cell carcinoma: systematic review. Clin. Genitourin. Cancer 17, e345–e355 (2019).

Article  PubMed  Google Scholar 

Shinagare, A. B. et al. Lexicon for renal mass terms at CT and MRI: a consensus of the society of abdominal radiology disease-focused panel on renal cell carcinoma. Abdom. Radiol. 46, 703–722 (2021).

Article  Google Scholar 

Hindman, N. et al. Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology 265, 468–477 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Choudhary, S., Rajesh, A., Mayer, N. J., Mulcahy, K. A. & Haroon, A. Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. Clin. Radiol. 64, 517–522 (2009).

Article  CAS  PubMed  Google Scholar 

Ljungberg, B. et al. EAU Guidelines on Renal Cell Carcinoma. European Association of Urology https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Renal-Cell-Carcinoma-2024.pdf (2024).

Sountoulides, P., Metaxa, L. & Cindolo, L. Atypical presentations and rare metastatic sites of renal cell carcinoma: a review of case reports. J. Med. Case Rep. 5, 429 (2011).

Article  PubMed  PubMed Central  Google Scholar 

Angelelli, G., Mancini, M., Pignataro, P., Pedote, P. & Scardapane, A. Multidetector computed tomography in the study of pancreatic metastases. Radiol. Med. 117, 369–377 (2012).

Article  CAS  PubMed  Google Scholar 

Roussel, E. et al. Novel imaging methods for renal mass characterization: a collaborative review. Eur. Urol. 81, 476–488 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Chakraborty, S., Balan, M., Sabarwal, A., Choueiri, T. K. & Pal, S. Metabolic reprogramming in renal cancer: events of a metabolic disease. Biochim. Biophys. Acta Rev. Cancer 1876, 188559 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu, J. et al. Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression. Nat. Genet. 56, 442–457 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao, Y. et al. 2-[18F]FDG PET/CT parameters associated with WHO/ISUP grade in clear cell renal cell carcinoma. Eur. J. Nucl. Med. Mol. Imaging 48, 570–579 (2021).

Article  PubMed  Google Scholar 

Alongi, P. et al. Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT. Eur. J. Nucl. Med. Mol. Imaging 43, 464–473 (2016).

Article  CAS  PubMed  Google Scholar 

Schug, Z. T. et al. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell 27, 57–71 (2015).

Article  CAS